Confidential opportunity to acquire or strategically partner with an established licensed retail pharmacy platform located in the Pearland / Greater Houston, Texas market. The business operates from an existing pharmacy facility and combines traditional prescription dispensing with third-party payer/PBM access, delivery and digital capabilities, a two-pharmacist team, and sterile/non-sterile compounding equipment and infrastructure available.

The pharmacy has demonstrated the ability to process prescriptions across a broad payer base, with historical activity involving major commercial and government channels. Current/historical documentation includes CVS Caremark-related activity, Medicare Part D, Humana, Aetna, Optum / Prescription Solutions and other managed-care payers. The operating platform provides a potential strategic buyer with an existing licensed pharmacy, personnel, dispensing workflow and reimbursement infrastructure rather than requiring a greenfield build.

Company reporting for 2025 reflects approximately $1.98 million of prescription revenue, approximately $1.38 million of prescription-level gross profit and approximately 2,221 prescriptions, representing a reported Rx-level gross margin of approximately 69.9%. The supplied 2026 transaction file through the available period contains 880 fill transactions, approximately $486,000 of revenue, approximately $172,000 of acquisition cost and approximately $314,000 of reported transaction-level gross profit. These pharmacy-system figures are operating metrics and should not be interpreted as audited GAAP financial statements.

Revenue has declined from prior peak periods, creating a different type of strategic opportunity: the facility, pharmacy licenses, payer relationships, pharmacist staffing and available compounding infrastructure may have significant value to an operator capable of introducing immediate prescription or fulfillment volume. Ownership is willing to entertain significant and meaningful strategic arrangements with qualified parties that can bring business to the platform, including fulfillment agreements, joint ventures, strategic investments and acquisition structures involving continued seller equity participation.

The pharmacy also has sterile and non-sterile compounding equipment available and is positioned for further development of personalized medicine and compounding services, subject to all applicable licensing, certification, regulatory and operational requirements. This creates potential upside for a qualified operator seeking an existing pharmacy base from which to build higher-value prescription, provider, telehealth, wellness or compounding programs.

Key Investment Highlights

·        Licensed Operating Platform – Existing Texas Class A Retail Pharmacy License and DEA registration, with an established Pearland pharmacy facility.

·        Existing PBM / Payer Access – Contracted across various commercial, Medicare, Medicaid and managed-care channels, including CVS Caremark related activity.

·        Two-Pharmacist Team – Existing pharmacist staffing (1 Pharmacist, 1 Pharmacist Owner, 2 Techs) supports continuity and provides an operating base for incremental prescription volume.

·        Compounding Infrastructure Ready for Deployment – 503a Sterile and non-sterile compounding equipment and related infrastructure are available and positioned for growth, subject to applicable regulatory requirements **NOT LICENSED / APPROVED AS 503a STERILE FACILITY**

·        Attractive Historical Rx-Level Economics – 2025 pharmacy-system reporting reflects approximately $1.98M of Rx revenue and approximately $1.38M of Rx-level gross profit. 2026 Revenue has seen a significant decline, at $486k Gross Revenue through Sept 2026.

·        Strategic Fulfillment Capacity – Existing pharmacy infrastructure may allow a strategic buyer or partner to introduce prescription volume without creating a pharmacy platform from the ground up.

·        Flexible Transaction Structures – Seller is open to meaningful fulfillment, JV, strategic investment and equity-roll opportunities with qualified counterparties capable of bringing immediate business.

·        Greater Houston Location – Pearland provides access to the large and growing Houston metropolitan healthcare market.